Inventor

DAVIS SAMUEL

US70 patents

⚠️ This page may combine multiple inventors who share the name “DAVIS SAMUEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DAVIS SAMUEL

REGENERON PHARMA

Cell culture compositions capable of producing a VEGF-binding fusion polypeptide

Modified chimeric polypeptides with improved pharmacokinetic properties

Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides

Modified chimeric polypeptides with improved pharmacokinetic properties

Modified chimeric polypeptides with improved pharmacokinetic properties

Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof

Modified chimeric polypeptides with improved pharmacokinetic properties

TIE-2 ligand, and method of making

Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties

Modified chimeric polypeptides with improved pharmacokinetic properties

Modified chimeric polypeptides with improved pharmacokinetic properties

Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF

Genome mutation by intron insertion into an embryonic stem cell genome

Tie-2 ligand 1

Antibodies comprising chimeric constant domains

Antibodies to human TIE-2 ligands

Nucleic acids encoding TIE-2 ligand-2

Tie-2 ligand 2

Nucleic acid encoding tie-2 ligand

Expressed ligand—vascular intercellular signalling molecule

Expressed ligand-vascular intercellular signalling molecule

Expressed ligand-vascular intercellular signalling molecule

Ciliary neurotrophic factor receptor

TIE-2 ligands, methods of making and uses thereof

Method of enhancing the biological activity of Eph family ligands

Heavy chain constant regions with reduced binding to Fc gamma receptors

Heavy chain constant regions with reduced binding to Fc gamma receptors

Antibodies comprising chimeric constant domains

Methods and antibody compositions for tumor treatment

Antibodies comprising chimeric constant domains

TIE-2 ligands, methods of making and uses thereof

Readily isolated bispecific antibodies with native immunoglobulin format

Method of enhancing the biological activity of ligands

Methods of treatment using ciliary neurotrophic factor

Tie-2 ligands

Antibodies comprising chimeric constant domains

Expressed ligand-vascular intercellular signaling molecule

Mammalian expression vector

Methods and antibody compositions for tumor treatment

Glucagon-like peptide 1 receptor agonists and uses thereof

Ciliary neurotrophic factor receptor antibodies

Nucleic acid molecule encoding ciliary neurotrophic factor receptor

Antigen binding molecule formats

Antigen binding molecule formats

Antigen binding molecule formats

Readily isolated bispecific antibodies with native immunoglobulin format

PAPADOPOULOS NICHOLAS J

Methods for producing a fusion protein capable of binding VEGF

Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF

DAVIS SAMUEL

Readily isolated bispecific antibodies with native immunoglobulin format

Kinetic display assembly